Latest news
Incyte (INCY) Wins EU Approval For Opzelura In Adult Moderate Atopic Dermatitis - Yahoo FinanceYahoo Finance · Sat, 01 Aug 2026 07:00:00 GMTEC approves Opzelura for moderate atopic dermatitis - The Pharma LetterThe Pharma Letter · Wed, 29 Jul 2026 07:00:00 GMTOpzelura® (ruxolitinib) Cream Becomes First Steroid-Free Topical JAK Inhibitor Approved in the European Union for Adults with Moderate Atopic Dermatitis - Yahoo FinanceYahoo Finance · Wed, 29 Jul 2026 07:00:00 GMT